UC Scientist Wins Parkinson's Research Award
Kim Seroogy, PhD, professor in the UC Department of Neurology, has received a $250,000 grant from the Michael J. Fox Foundations 2004 Community Fast Track Program.
Dr. Seroogys team in the Selma Schottenstein Harris Laboratory for Research in Parkinsons Disease at UC will study the potential therapeutic value of two proteins from the neuregulin family of growth factors. Their goal is to identify the best candidate for future preclinical testing.
Six national and local Parkinsons disease groups and a charitable trust teamed with the Fox Foundation to award more than $3.6 million to 18 outstanding researchers around the world.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.